Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 22

1.

Nanoparticle mediated silencing of tenascin C in hepatic stellate cells: effect on inflammatory gene expression and cell migration.

Vivero-Escoto JL, Vadarevu H, Juneja R, Schrum LW, Benbow JH.

J Mater Chem B. 2019 Dec 14;7(46):7396-7405. doi: 10.1039/c9tb01845j. Epub 2019 Nov 8.

PMID:
31701111
2.

Multimodal Polysilsesquioxane Nanoparticles for Combinatorial Therapy and Gene Delivery in Triple-Negative Breast Cancer.

Juneja R, Lyles Z, Vadarevu H, Afonin KA, Vivero-Escoto JL.

ACS Appl Mater Interfaces. 2019 Apr 3;11(13):12308-12320. doi: 10.1021/acsami.9b00704. Epub 2019 Mar 19.

PMID:
30844224
3.

Influence of Cationic meso-Substituted Porphyrins on the Antimicrobial Photodynamic Efficacy and Cell Membrane Interaction in Escherichia coli.

Hurst AN, Scarbrough B, Saleh R, Hovey J, Ari F, Goyal S, Chi RJ, Troutman JM, Vivero-Escoto JL.

Int J Mol Sci. 2019 Jan 1;20(1). pii: E134. doi: 10.3390/ijms20010134.

4.

Mucin-1-Antibody-Conjugated Mesoporous Silica Nanoparticles for Selective Breast Cancer Detection in a Mucin-1 Transgenic Murine Mouse Model.

Dréau D, Moore LJ, Alvarez-Berrios MP, Tarannum M, Mukherjee P, Vivero-Escoto JL.

J Biomed Nanotechnol. 2016 Dec;12(12):2172-2184. doi: 10.1166/jbn.2016.2318.

5.

In vitro evaluation of folic acid-conjugated redox-responsive mesoporous silica nanoparticles for the delivery of cisplatin.

Alvarez-Berríos MP, Vivero-Escoto JL.

Int J Nanomedicine. 2016 Nov 23;11:6251-6265. eCollection 2016.

6.

Cellular Endocytosis and Trafficking of Cholera Toxin B-Modified Mesoporous Silica Nanoparticles.

Walker WA, Tarannum M, Vivero-Escoto JL.

J Mater Chem B. 2016 Feb 21;4(7):1254-1262. Epub 2016 Jan 7.

7.

Redox-Responsive Porphyrin-Based Polysilsesquioxane Nanoparticles for Photodynamic Therapy of Cancer Cells.

Vega DL, Lodge P, Vivero-Escoto JL.

Int J Mol Sci. 2015 Dec 31;17(1). pii: E56. doi: 10.3390/ijms17010056.

8.

Mesoporous Silica Nanoparticles Loaded with Cisplatin and Phthalocyanine for Combination Chemotherapy and Photodynamic Therapy in vitro.

Vivero-Escoto JL, Elnagheeb M.

Nanomaterials (Basel). 2015 Dec 16;5(4):2302-2316. doi: 10.3390/nano5042302.

9.

Polysilsesquioxane nanoparticles for triggered release of cisplatin and effective cancer chemoradiotherapy.

Rocca JD, Werner ME, Kramer SA, Huxford-Phillips RC, Sukumar R, Cummings ND, Vivero-Escoto JL, Wang AZ, Lin W.

Nanomedicine. 2015 Jan;11(1):31-8. doi: 10.1016/j.nano.2014.07.004. Epub 2014 Jul 17.

10.

Biodegradable polysilsesquioxane nanoparticles as efficient contrast agents for magnetic resonance imaging.

Vivero-Escoto JL, Rieter WJ, Lau H, Huxford-Phillips RC, Lin W.

Small. 2013 Oct 25;9(20):3523-31. doi: 10.1002/smll.201300198. Epub 2013 Apr 24.

11.

Recent progress in mesoporous titania materials: adjusting morphology for innovative applications.

Vivero-Escoto JL, Chiang YD, Wu K, Yamauchi Y.

Sci Technol Adv Mater. 2012 Feb 2;13(1):013003. eCollection 2012 Feb. Review.

12.

Silica-based nanoprobes for biomedical imaging and theranostic applications.

Vivero-Escoto JL, Huxford-Phillips RC, Lin W.

Chem Soc Rev. 2012 Apr 7;41(7):2673-85. doi: 10.1039/c2cs15229k. Epub 2012 Jan 10. Review.

13.

Multifunctional mesoporous silica nanospheres with cleavable Gd(III) chelates as MRI contrast agents: synthesis, characterization, target-specificity, and renal clearance.

Vivero-Escoto JL, Taylor-Pashow KM, Huxford RC, Della Rocca J, Okoruwa C, An H, Lin W, Lin W.

Small. 2011 Dec 16;7(24):3519-28. doi: 10.1002/smll.201100521. Epub 2011 Nov 9.

14.

Inorganic-organic hybrid nanomaterials for therapeutic and diagnostic imaging applications.

Vivero-Escoto JL, Huang YT.

Int J Mol Sci. 2011;12(6):3888-927. doi: 10.3390/ijms12063888. Epub 2011 Jun 10. Review.

15.

Surfactant-assisted controlled release of hydrophobic drugs using anionic surfactant templated mesoporous silica nanoparticles.

Tsai CH, Vivero-Escoto JL, Slowing II, Fang IJ, Trewyn BG, Lin VS.

Biomaterials. 2011 Sep;32(26):6234-44. doi: 10.1016/j.biomaterials.2011.04.077. Epub 2011 Jun 17.

PMID:
21684000
16.

Exocytosis of mesoporous silica nanoparticles from mammalian cells: from asymmetric cell-to-cell transfer to protein harvesting.

Slowing II, Vivero-Escoto JL, Zhao Y, Kandel K, Peeraphatdit C, Trewyn BG, Lin VS.

Small. 2011 Jun 6;7(11):1526-32. doi: 10.1002/smll.201002077. Epub 2011 Apr 26. No abstract available.

PMID:
21520497
17.

Capped mesoporous silica nanoparticles as stimuli-responsive controlled release systems for intracellular drug/gene delivery.

Zhao Y, Vivero-Escoto JL, Slowing II, Trewyn BG, Lin VS.

Expert Opin Drug Deliv. 2010 Sep;7(9):1013-29. doi: 10.1517/17425247.2010.498816. Review.

PMID:
20716017
18.

Mesoporous silica nanoparticles for intracellular controlled drug delivery.

Vivero-Escoto JL, Slowing II, Trewyn BG, Lin VS.

Small. 2010 Sep 20;6(18):1952-67. doi: 10.1002/smll.200901789. Review.

PMID:
20690133
19.

Tuning the cellular uptake and cytotoxicity properties of oligonucleotide intercalator-functionalized mesoporous silica nanoparticles with human cervical cancer cells HeLa.

Vivero-Escoto JL, Slowing II, Lin VS.

Biomaterials. 2010 Feb;31(6):1325-33. doi: 10.1016/j.biomaterials.2009.11.009. Epub 2009 Nov 24.

PMID:
19932923
20.

Photoinduced intracellular controlled release drug delivery in human cells by gold-capped mesoporous silica nanosphere.

Vivero-Escoto JL, Slowing II, Wu CW, Lin VS.

J Am Chem Soc. 2009 Mar 18;131(10):3462-3. doi: 10.1021/ja900025f.

PMID:
19275256

Supplemental Content

Loading ...
Support Center